We are pleased to invite investors and analysts to participate in a live video webcast and conference call on Monday, 27 July, 2020, highlighting Roche data accepted for presentation via the ASRS 2020 Virtual Scientific Program July 24-26, 2020.
16:30 – 17:30 CEST / 15:30 - 16:30 BST
10:30 – 11:30 am EDT / 7:30 – 8:30 am PDT
Video webcast and conference call will start with a presentation, followed by a Q&A session (live access to the speakers).
Access to video webcast and conference call
Dial in details will soon follow.
A replay of the webcast will be available via > ir.roche.com
| Best regards, | |
| Karl Mahler Head of Investor Relations and Roche Group Planning | Lisa Tuomi Investor Relations Officer |
| Roche Investor Relations | |
| Dr. Karl Mahler Phone: +41 61 68-78503 e-mail: karl.mahler@roche.com | Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com |
| Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com | Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com |
| Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com | Jon Kaspar Bayard Phone: +41 61 68-83894 e-mail: jon_kaspar.bayard@roche.com |
| Investor Relations North America | |
| Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com | Dr. Lisa Tuomi Phone: +1 650 467 8737 e-mail: tuomi.lisa@gene.com |
Attachment
get the latest news and updates to your inbox.